Aditxt (ADTX) Current Deferred Revenue (2020 - 2026)
Aditxt (ADTX) recorded quarterly Current Deferred Revenue of $39243.0 in Q1 2026, down 26.57% quarter-over-quarter from $53443.0 in Q4 2025, and down 58.38% on a YoY basis from $94300.0 in Q1 2025.
Aditxt (ADTX) Current Deferred Revenue (2020 - 2026) Analysis & Trends
Aditxt's Current Deferred Revenue history runs 7 years deep, the most recent figure standing at $39243.0 for Q1 2026.
- In Q1 2026, Current Deferred Revenue fell 58.38% year-over-year to $39243.0; the TTM figure through Mar 2026 stood at $39243.0 (down 58.38% YoY), while the FY2025 annual figure was $53443.0, down 49.62% from the prior year.
- Current Deferred Revenue was $39243.0 for Q1 2026 at Aditxt, down from $53443.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $192984.0 in Q2 2022 to a low of $39243.0 in Q1 2026.
- Historically, Current Deferred Revenue has averaged $134565.6 across 5 years, with a median of $147350.0 in 2024.
- The sharpest annual moves came in 2022 and 2026: Current Deferred Revenue surged 1727.48% in 2022, then plunged 58.38% in 2026.
- A 5-year view of Current Deferred Revenue shows it stood at $188581.0 in 2022, then retreated by 15.89% to $158612.0 in 2023, then slumped by 33.12% to $106075.0 in 2024, then sank by 49.62% to $53443.0 in 2025, then fell by 26.57% to $39243.0 in 2026.
- The last three Current Deferred Revenue figures came in at $39243.0 (Q1 2026), $53443.0 (Q4 2025), and $62046.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Aditxt | 2,485.68 | -2.16 Mn | 2,868.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39,243.00 |
| Dec 31, 2025 | 53,443.00 |
| Sep 30, 2025 | 62,046.00 |
| Jun 30, 2025 | 79,044.00 |
| Mar 31, 2025 | 94,300.00 |
| Dec 31, 2024 | 106,075.00 |
| Sep 30, 2024 | 117,850.00 |
| Jun 30, 2024 | 130,933.00 |
| Mar 31, 2024 | 147,350.00 |
| Dec 31, 2023 | 158,612.00 |
| Sep 30, 2023 | 169,633.00 |
| Jun 30, 2023 | 179,302.00 |
| Mar 31, 2023 | 185,586.00 |
| Dec 31, 2022 | 188,581.00 |
| Sep 30, 2022 | 191,515.00 |
| Jun 30, 2022 | 192,984.00 |
| Mar 31, 2022 | 191,118.00 |
| Dec 31, 2021 | 186,058.00 |
| Sep 30, 2021 | 180,940.00 |
| Jun 30, 2021 | 122,632.00 |